Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Drug susceptibility of matrix-encapsulated Candida albicans nano-biofilms.

Srinivasan A, Gupta CM, Agrawal CM, Leung KP, Lopez-Ribot JL, Ramasubramanian AK.

Biotechnol Bioeng. 2014 Feb;111(2):418-24. doi: 10.1002/bit.25120. Epub 2013 Oct 18.

2.

Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms.

Delattin N, De Brucker K, Vandamme K, Meert E, Marchand A, Chaltin P, Cammue BP, Thevissen K.

J Antimicrob Chemother. 2014 Apr;69(4):1035-44. doi: 10.1093/jac/dkt449. Epub 2013 Nov 27.

PMID:
24284780
3.

A novel assay of biofilm antifungal activity reveals that amphotericin B and caspofungin lyse Candida albicans cells in biofilms.

DiDone L, Oga D, Krysan DJ.

Yeast. 2011 Aug;28(8):561-8. doi: 10.1002/yea.1860. Epub 2011 Jun 15.

4.

In vitro activity of antifungal combinations against Candida albicans biofilms.

Tobudic S, Kratzer C, Lassnigg A, Graninger W, Presterl E.

J Antimicrob Chemother. 2010 Feb;65(2):271-4. doi: 10.1093/jac/dkp429. Epub 2009 Dec 8.

PMID:
19996142
5.

Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases.

Tobudic S, Lassnigg A, Kratzer C, Graninger W, Presterl E.

Mycoses. 2010 May;53(3):208-14. doi: 10.1111/j.1439-0507.2009.01690.x. Epub 2009 Feb 26.

PMID:
19298353
6.

Effects of fluconazole, amphotericin B, and caspofungin on Candida albicans biofilms under conditions of flow and on biofilm dispersion.

Uppuluri P, Srinivasan A, Ramasubramanian A, Lopez-Ribot JL.

Antimicrob Agents Chemother. 2011 Jul;55(7):3591-3. doi: 10.1128/AAC.01701-10. Epub 2011 Apr 25.

7.

Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A.

Shinde RB, Chauhan NM, Raut JS, Karuppayil SM.

Ann Clin Microbiol Antimicrob. 2012 Oct 4;11:27. doi: 10.1186/1476-0711-11-27.

8.

Candida albicans biofilm chip (CaBChip) for high-throughput antifungal drug screening.

Srinivasan A, Lopez-Ribot JL, Ramasubramanian AK.

J Vis Exp. 2012 Jul 18;(65):e3845. doi: 10.3791/3845.

9.

Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model.

Shuford JA, Rouse MS, Piper KE, Steckelberg JM, Patel R.

J Infect Dis. 2006 Sep 1;194(5):710-3. Epub 2006 Jul 28.

PMID:
16897672
10.

Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms.

Martins M, Henriques M, Lopez-Ribot JL, Oliveira R.

Mycoses. 2012 Jan;55(1):80-5. doi: 10.1111/j.1439-0507.2011.02047.x. Epub 2011 Jun 12.

11.

[In vitro activity of amphotericin B and anidulafungin against Candida spp. biofilms].

Valentín A, Cantón E, Pemán J, Quindós G.

Rev Iberoam Micol. 2007 Dec 31;24(4):272-7. Spanish.

12.

Quinacrine inhibits Candida albicans growth and filamentation at neutral pH.

Kulkarny VV, Chavez-Dozal A, Rane HS, Jahng M, Bernardo SM, Parra KJ, Lee SA.

Antimicrob Agents Chemother. 2014 Dec;58(12):7501-9. doi: 10.1128/AAC.03083-14. Epub 2014 Oct 6.

13.

Chloroquine sensitizes biofilms of Candida albicans to antifungal azoles.

Shinde RB, Raut JS, Chauhan NM, Karuppayil SM.

Braz J Infect Dis. 2013 Jul-Aug;17(4):395-400. doi: 10.1016/j.bjid.2012.11.002. Epub 2013 Apr 18.

14.

In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms.

Ko KS, Lee JY, Song JH, Peck KR.

J Korean Med Sci. 2010 Dec;25(12):1722-6. doi: 10.3346/jkms.2010.25.12.1722. Epub 2010 Nov 24.

15.

Liposomal amphotericin B displays rapid dose-dependent activity against Candida albicans biofilms.

Ramage G, Jose A, Sherry L, Lappin DF, Jones B, Williams C.

Antimicrob Agents Chemother. 2013 May;57(5):2369-71. doi: 10.1128/AAC.02344-12. Epub 2013 Feb 19.

16.
17.

Synergistic activity of the tyrocidines, antimicrobial cyclodecapeptides from Bacillus aneurinolyticus, with amphotericin B and caspofungin against Candida albicans biofilms.

Troskie AM, Rautenbach M, Delattin N, Vosloo JA, Dathe M, Cammue BP, Thevissen K.

Antimicrob Agents Chemother. 2014 Jul;58(7):3697-707. doi: 10.1128/AAC.02381-14. Epub 2014 Apr 21.

18.

Caspofungin at catheter lock concentrations eradicates mature biofilms of Candida lusitaniae and Candida guilliermondii.

Simitsopoulou M, Kyrpitzi D, Velegraki A, Walsh TJ, Roilides E.

Antimicrob Agents Chemother. 2014 Aug;58(8):4953-6. doi: 10.1128/AAC.03117-14. Epub 2014 Jun 2.

19.

Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.

Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA.

Antimicrob Agents Chemother. 2002 Jun;46(6):1773-80.

20.

The nonsteroidal antiinflammatory drug diclofenac potentiates the in vivo activity of caspofungin against Candida albicans biofilms.

Bink A, Kucharíková S, Neirinck B, Vleugels J, Van Dijck P, Cammue BP, Thevissen K.

J Infect Dis. 2012 Dec 1;206(11):1790-7. doi: 10.1093/infdis/jis594. Epub 2012 Sep 14.

PMID:
22984120

Supplemental Content

Support Center